Efficacy and safety of hybutimibe in combination with atorvastatin for treatment of hypercholesteremia among patients with atherosclerotic cardiovascular disease risk equivalent: A multicenter, randomized, double-blinded phase III study

BACKGROUND: To evaluate the safety and efficacy of hybutimibe plus atorvastatin for lipid control in hypercholesterolemia patients with atherosclerotic cardiovascular disease risk equivalent. METHODS: In this double-blind phase III study, we 1:1 randomly assigned 255 hypercholesterolemia patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Litong, Chen, Jiyan, Li, Xiaodong, Qi, Xiaoyong, Ding, Chunhua, Chen, Xiaoping, Gu, Xiang, Xiao, Wenliang, Zhao, Shuiping, Dong, Yugang, Zheng, Mingqi, Huang, Kai, Tang, Liangqiu, Guo, Xiaomei, Wang, Fang, Fu, Guosheng, Li, Junxia, Huo, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9443664/
https://www.ncbi.nlm.nih.gov/pubmed/36072875
http://dx.doi.org/10.3389/fcvm.2022.888604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9443664/
https://www.ncbi.nlm.nih.gov/pubmed/36072875
http://dx.doi.org/10.3389/fcvm.2022.888604

Ejemplares similares